Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes.

about

Introduction to Hanefeld Symposium: 40+ years of metabolic syndrome.

P2860

Q54422903-385BE630-2E8C-4579-A2DB-314B33998413

P2860

Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes.

Item

http://www.wikidata.org/entity/Q38815498

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Outcome studies and safety as ...... patients with type 2 diabetes.

@en

type

Item

label

Outcome studies and safety as ...... patients with type 2 diabetes.

@en

prefLabel

Outcome studies and safety as ...... patients with type 2 diabetes.

@en

P1476

Outcome studies and safety as ...... patients with type 2 diabetes.

@en

P2093

Avivit Cahn

http://www.w3.org/2001/XMLSchema#string

Itamar Raz

http://www.w3.org/2001/XMLSchema#string

Simona Cernea

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

P2888

s11154-016-9351-6

P304

117-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11154-016-9351-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1031492333

http://www.w3.org/2001/XMLSchema#string

P698

27106831

http://www.w3.org/2001/XMLSchema#string

Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes.

about

P2860

P2860

Outcome studies and safety as guide for decision making in treating patients with type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698